(CDIV) Manulife Smart Dividend - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA56502U1084 • Canadian Dividend and Income Equity
CDIV: Canadian Dividend Stocks, Income Equity Investments
The Manulife Smart Dividend ETF (CDIV) is a Canadian dividend-focused exchange-traded fund (ETF) designed to provide investors with a diversified portfolio of dividend-paying stocks. By tracking the Morningstar Canada GR CAD Index, CDIV aims to capture the performance of the Canadian equity markets dividend-paying segment.
CDIVs underlying index is constructed using a rules-based methodology that emphasizes dividend yield, dividend growth, and payout ratio, among other factors. This approach is designed to identify companies with a history of stable dividend payments and a potential for future dividend growth. The funds portfolio is likely comprised of a mix of large-cap Canadian stocks across various sectors, with a bias towards companies with a strong dividend track record.
From a technical analysis perspective, CDIVs price action suggests a bullish trend, with the ETF trading above its 20-day, 50-day, and 200-day simple moving averages (SMA). The Average True Range (ATR) indicates moderate volatility, with a recent ATR of 0.22 representing approximately 1.47% of the current price. Given the current technical setup, its likely that CDIV will continue to trade within a relatively narrow range, potentially consolidating around the 15.00 level before making its next move.
Combining technical and fundamental insights, a forecast for CDIV can be constructed. With a current dividend yield likely in the range of 4-5% based on its underlying holdings, CDIV may continue to attract income-seeking investors. The funds AUM of 644.28M CAD suggests a reasonable level of liquidity, which can help to support its price. Assuming the Canadian economy continues to grow at a moderate pace, and dividend-paying stocks remain in favor, CDIV may be poised to trade towards its 52-week high of 15.24 in the near term, potentially reaching 15.50 in a bullish scenario.
Its essential to note that this forecast is based on the assumption that the underlying fundamentals of the Canadian economy and the dividend-paying stocks within CDIVs portfolio remain intact. Any significant changes to these underlying factors could impact CDIVs performance and should be closely monitored.
Additional Sources for CDIV ETF
CDIV ETF Overview
Market Cap in USD | 461m |
Category | Canadian Dividend and Income Equity |
IPO / Inception | 2020-11-25 |
CDIV ETF Ratings
Growth Rating | 73.9 |
Fundamental | - |
Dividend Rating | 69.2 |
Rel. Strength | 2.39 |
Analysts | - |
Fair Price Momentum | 16.32 CAD |
Fair Price DCF | - |
CDIV Dividends
Dividend Yield 12m | 3.67% |
Yield on Cost 5y | 6.11% |
Annual Growth 5y | 135.12% |
Payout Consistency | 83.3% |
CDIV Growth Ratios
Growth Correlation 3m | 35.8% |
Growth Correlation 12m | 73.1% |
Growth Correlation 5y | 88.6% |
CAGR 5y | 12.68% |
CAGR/Max DD 5y | 0.77 |
Sharpe Ratio 12m | 2.42 |
Alpha | 6.21 |
Beta | 0.444 |
Volatility | 9.39% |
Current Volume | 6k |
Average Volume 20d | 6.2k |
As of May 15, 2025, the stock is trading at CAD 15.32 with a total of 6,026 shares traded.
Over the past week, the price has changed by +1.59%, over one month by +5.29%, over three months by +4.44% and over the past year by +14.80%.
Yes. Based on ValueRay Analyses, Manulife Smart Dividend (TO:CDIV) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.90 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CDIV as of May 2025 is 16.32. This means that CDIV is currently overvalued and has a potential downside of 6.53%.
Manulife Smart Dividend has no consensus analysts rating.
According to ValueRays Forecast Model, CDIV Manulife Smart Dividend will be worth about 18.2 in May 2026. The stock is currently trading at 15.32. This means that the stock has a potential upside of +18.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 18.2 | 18.6% |